No black box warning on record for Oraverse

As of the latest FDA labeling reviewed, Oraverse (PHENTOLAMINE MESYLATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Oraverse medicine page for the complete safety profile.

Other warnings & precautions

5. WARNINGS AND PRECAUTIONS Myocardial infarction, cerebrovascular spasm, and cerebrovascular occlusion have been reported to occur following the intravenous or intramuscular administration of phentolamine, usually in association with marked hypotensive episodes or shock-like states which occasionally follow parenteral administration. Tachycardia and cardiac arrhythmiasmay occur with the use of ph

No black box warning on record for Oraverse

Other warnings & precautions

5. WARNINGS AND PRECAUTIONS Myocardial infarction, cerebrovascular spasm, and cerebrovascular occlusion have been reported to occur following the intravenous or intramuscular administration of phentolamine, usually in association with marked hypotensive episodes or shock-like states which occasionally follow parenteral administration. Tachycardia and cardiac arrhythmiasmay occur with the use of ph

Oraverse Black Box Warning

No black box warning on record for Oraverse

Other warnings & precautions

Oraverse Black Box Warning

No black box warning on record for Oraverse

Other warnings & precautions